Clinical Trial: Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06793241) titled 'Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia' on Jan. 16.

Brief Summary: A Clinical Study on the Safety and Effectiveness of donor derived CD19 CAR-T Cells in the treatment of R/R B-cell acute lymphoblastic leukemia

Study Start Date: Jan. 31

Study Type: INTERVENTIONAL

Condition: B-cell Acute Lymphoblastic Leukemia

Intervention: BIOLOGICAL: CD19 B-cell Acute Lymphoblastic Leukemia Targeted CAR T-cells injection

Each subject receive CD19 B-cell Acute Lymphoblastic Leukemia Targeted CAR T-cells by intravenous infusion

Recruitment Status: RECRUITING

Sponsor: Zhejiang University

Inf...